Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials

Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials

Abstract Aims/Introduction To assess the impact of baseline characteristics on the efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes. Materials and Methods In the Peptide InnOvatioN for Early diabEtes tReatment (PIONEER) 9 and 10 trials, Japanese patients were randomi...

Full description

Bibliographic Details
Main Authors: Daisuke Yabe, Srikanth Deenadayalan, Hiroshi Horio, Hideaki Kaneto, Thomas Bo Jensen, Yasuo Terauchi, Yuichiro Yamada, Nobuya Inagaki
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Journal of Diabetes Investigation
Subjects:
Glucagon‐like peptide‐1 analog
Glycemic control
Type 2 diabetes
Online Access:https://doi.org/10.1111/jdi.13764

Internet

https://doi.org/10.1111/jdi.13764

Similar Items